Ascopharm GmbH is a developer and supplier of high-quality dietary supplements, over-the-counter drugs as well as minerals, vitamins and cosmetics. Adiuva Capital acquired the company, which was founded in 1977, as part of a company succession initiative from Karl-Heinz Oppermann in 2012.
Ascopharm supplies over two hundred thousand regular customers from its headquarters in Wernigerode. All products are manufactured and tested in accordance with GMP guidelines to ensure that high product quality is always maintained.
Adiuva Capital supported Ascopharm in expanding the company's product portfolio, promoting the expansion of its B2B business and strengthening its online business.
In 2019 Ascopharm was acquired by point-rouge GmbH.